Related Articles
Drugmaker caps insulin costs at $35 to help diabetes patients during pandemic
Pharmaceutical manufacturer Eli Lilly said Tuesday that it will limit the out-of-pocket cost of insulin to $35 per month to offset financial hardships due to the coronavirus pandemic. The co-pay cap will cover the majority of the company’s insulin, including the Humalog injection, and is open to the uninsured as well as commercially insured people, […]
‘Medication or housing’: why soaring insulin prices are killing Americans
Jada Renee Louis of Newport News, Virginia, died on 22 June 2019 about a week after requiring emergency hospital care for diabetic ketoacidosis, a serious complication caused by a lack of insulin, and a foot ulcer. She was 24. A type 1 diabetic, Louis, who did not have health insurance coverage, couldn’t afford the cost […]
Manufacturing Novel Stem Cell Products To Treat Type 1 Diabetes
The ISLET project, a multi-center collaboration of leading European researchers, aims to develop a manufacturing pipeline for stem cell-based products to treat patients with Type 1 Diabetes. In Type 1 Diabetes a patient’s immune system destroys the beta cells within the islets of Langerhans in the pancreas making a patient depend-ent on life-long delivery of […]